{"slug":"pt-141-postherpetic","verification":{"valid":true,"entries":2,"head":"261cf22a04c3b7b3f1cc2537052a359c0074e60c1c18629d6c8fa6c1a1146a7d"},"energy":{"passes":2,"tokens_in":12683,"tokens_out":2834,"tokens_total":15517,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"261cf22a04c3b7b3f1cc2537052a359c0074e60c1c18629d6c8fa6c1a1146a7d"},"provenance":[{"ts":"2026-06-30T01:09:55.136Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Postherpetic\nSlug: pt-141-postherpetic\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from","response":"{\n  \"slug\": \"pt-141-postherpetic\",\n  \"title\": \"PT-141 for Postherpetic Neuralgia: A Data-First Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nPostherpetic neuralgia develops after shingles when the varicella-zoster virus damages sensory nerves. The rash heals but pain lingers for months or years in the same skin area.\\n\\nNerve fibers become hypersensitive. Damaged axons fire spontaneously. Central sensitization in the spinal cord and brain amplifies signals so light touch feels burning or stabbing.\\n\\nDegeneration outruns repair. Myelin sheaths thin. Inflammatory cytokines stay elevated. Blood flow to the affected dermatome drops. These changes keep the pain loop active.\\n\\nThe condition is neuropathic, not inflammatory like acute shingles. Standard treatments target ion channels or serotonin pathways to dampen signals. They do not restore nerve structure.\\n\\n## Why PT-141 might help you\\n\\nPT-141 acts on melanocortin receptors in the central nervous system. It influences arousal pathways that overlap with pain-modulation circuits.\\n\\n1. If your postherpetic pain includes a CNS arousal or sensory-processing layer, PT-141 is discussed because it engages melanocortin-4 receptors that modulate descending inhibitory signals.\\n2. If tissue-level nerve repair is part of the picture, the compound is framed around potential downstream effects on local blood flow and glial activity rather than direct pain masking.\\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nNo studies link PT-141 directly to postherpetic neuralgia. The logic rests on its known CNS mechanism and general melanocortin effects on neuroinflammation in other models.\\n\\n## How these fit together\\n\\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, siblings would address other layers such as local inflammation or sleep disrupti","tokens_in":12683,"tokens_out":2834,"cost":0,"prev":"genesis","hash":"2ec8b169b41e715a06ea1966eec8058786c21c274136b1bb7d20ee0f499c482b"},{"ts":"2026-07-17T02:41:09.389Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-postherpetic","response":"26 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"2ec8b169b41e715a06ea1966eec8058786c21c274136b1bb7d20ee0f499c482b","hash":"261cf22a04c3b7b3f1cc2537052a359c0074e60c1c18629d6c8fa6c1a1146a7d"}]}